- Home
- WT vs SPRY Comparison
WT vs SPRY Comparison
Compare WT & SPRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WT
- SPRY
- Stock Information
- Founded
- WT 1985
- SPRY 2015
- Country
- WT United States
- SPRY United States
- Employees
- WT N/A
- SPRY N/A
- Industry
- WT Investment Bankers/Brokers/Service
- SPRY Biotechnology: Pharmaceutical Preparations
- Sector
- WT Finance
- SPRY Health Care
- Exchange
- WT Nasdaq
- SPRY Nasdaq
- Market Cap
- WT 1.5B
- SPRY 1.6B
- IPO Year
- WT N/A
- SPRY N/A
- Fundamental
- Price
- WT $11.55
- SPRY $16.87
- Analyst Decision
- WT Buy
- SPRY Strong Buy
- Analyst Count
- WT 7
- SPRY 4
- Target Price
- WT $12.70
- SPRY $28.75
- AVG Volume (30 Days)
- WT 2.0M
- SPRY 1.4M
- Earning Date
- WT 07-25-2025
- SPRY 08-05-2025
- Dividend Yield
- WT 1.04%
- SPRY N/A
- EPS Growth
- WT N/A
- SPRY N/A
- EPS
- WT 0.37
- SPRY N/A
- Revenue
- WT $438,981,000.00
- SPRY $97,122,000.00
- Revenue This Year
- WT $7.75
- SPRY N/A
- Revenue Next Year
- WT $5.78
- SPRY $140.40
- P/E Ratio
- WT $31.44
- SPRY N/A
- Revenue Growth
- WT 20.66
- SPRY 971120.00
- 52 Week Low
- WT $7.47
- SPRY $8.35
- 52 Week High
- WT $12.45
- SPRY $18.90
- Technical
- Relative Strength Index (RSI)
- WT 78.27
- SPRY 58.88
- Support Level
- WT $10.16
- SPRY $16.16
- Resistance Level
- WT $11.60
- SPRY $18.90
- Average True Range (ATR)
- WT 0.25
- SPRY 0.93
- MACD
- WT 0.11
- SPRY 0.18
- Stochastic Oscillator
- WT 91.56
- SPRY 56.04
About WT WisdomTree Inc.
WisdomTree Inc is a financial innovator, offering a well-diversified suite of exchange-traded products (ETPs), models and solutions. It offers a broad range of ETFs and exchange-traded products (ETPs). The firm also engages in developing next-generation digital products and structures, including digital funds and tokenized assets, as well as its blockchain-native digital wallet, WisdomTree Prime. The Company conducts business under a single operating segment as an ETP sponsor and asset manager.
About SPRY ARS Pharmaceuticals Inc.
ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the development of novel, potentially first-in-class product candidate, neffy for the emergency treatment of Type I allergic reactions, including anaphylaxis. neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows neffy to provide injection-like absorption of epinephrine at a low dose, in a small, easy-to-carry, easy-to-use, rapidly administered and reliable nasal spray.